Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 2:09 pm Sale | 2023-12-31 | 13G | Immunocore Holdings plc IMCR | Rock Springs Capital Management LP | 2,661,507 5.380% | -659,559 (-19.86%) | Filing History |
| 2024-02-14 2:08 pm Unchanged | 2023-12-31 | 13G | GAMIDA CELL LTD GMDAQ | Rock Springs Capital Management LP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-02-14 2:07 pm Unchanged | 2023-12-31 | 13G | Spyre Therapeutics, Inc. SYRE | Rock Springs Capital Management LP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-02-14 2:06 pm Sale | 2023-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | Rock Springs Capital Management LP | 2,152,173 3.850% | -844,419 (-28.18%) | Filing History |
| 2024-02-14 2:06 pm Sale | 2023-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS | Rock Springs Capital Management LP | 2,998,495 4.230% | -962,754 (-24.30%) | Filing History |
| 2023-02-14 3:01 pm Sale | 2022-12-31 | 13G | Sierra Oncology, Inc. SRRA | Rock Springs Capital Management LP | 0 0.000% | -1,184,793 (Position Closed) | Filing History |
| 2023-02-14 3:01 pm Sale | 2022-12-31 | 13G | PhaseBio Pharmaceuticals, Inc. PHASQ | Rock Springs Capital Management LP | 0 0.000% | -2,581,299 (Position Closed) | Filing History |
| 2023-02-14 3:00 pm Purchase | 2022-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM | Rock Springs Capital Management LP | 1,795,733 4.870% | 256,919 (+16.70%) | Filing History |
| 2023-02-14 2:58 pm Purchase | 2022-12-31 | 13G | Compass Therapeutics, Inc. CMPX | Rock Springs Capital Management LP | 5,333,188 4.220% | 5,100 (+0.10%) | Filing History |
| 2023-02-14 2:57 pm Unchanged | 2022-12-31 | 13G | Tempest Therapeutics, Inc. TPST | Rock Springs Capital Management LP | 63,358 7.830% | 0 (Unchanged) | Filing History |
| 2023-02-14 2:56 pm Unchanged | 2022-12-31 | 13G | Spruce Biosciences, Inc. SPRB | Rock Springs Capital Management LP | 21,636 6.890% | 0 (Unchanged) | Filing History |
| 2023-02-14 2:55 pm Purchase | 2022-12-31 | 13G | Mereo BioPharma Group plc MREO | Rock Springs Capital Management LP | 31,224,485 5.340% | 25,638,864 (+459.02%) | Filing History |
| 2023-02-14 2:54 pm Purchase | 2022-12-31 | 13G | Inozyme Pharma, Inc. INZY | Rock Springs Capital Management LP | 3,086,027 7.640% | 633,390 (+25.82%) | Filing History |
| 2023-02-14 2:53 pm Purchase | 2022-12-31 | 13G | Immunocore Holdings plc IMCR | Rock Springs Capital Management LP | 3,321,066 7.330% | 849,511 (+34.37%) | Filing History |
| 2023-02-14 2:51 pm Purchase | 2022-12-31 | 13G | Aeglea BioTherapeutics, Inc. AGLE | Rock Springs Capital Management LP | 136,556 5.550% | 136,556 (New Position) | Filing History |
| 2023-02-14 2:50 pm Purchase | 2022-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | Rock Springs Capital Management LP | 2,996,592 5.450% | 2,996,592 (New Position) | Filing History |
| 2023-02-14 2:49 pm Purchase | 2022-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS | Rock Springs Capital Management LP | 3,961,249 5.940% | 99,902 (+2.59%) | Filing History |
| 2022-04-25 3:05 pm Purchase | 2022-04-14 | 13G | Inozyme Pharma, Inc. INZY | Rock Springs Capital Management LP | 2,452,637 6.120% | 2,452,637 (New Position) | Filing History |
| 2022-02-15 12:44 pm Purchase | 2021-12-31 | 13G | Mereo BioPharma Group plc MREO | Rock Springs Capital Management LP | 5,585,621 5.130% | 5,585,621 (New Position) | Filing History |
| 2022-02-14 6:27 pm Sale | 2021-12-31 | 13G | Protara Therapeutics, Inc. TARA | Rock Springs Capital Management LP | 0 0.000% | -643,200 (Position Closed) | Filing History |